HOME >> BIOLOGY >> NEWS
Identified mechanism in the malaria parasite to help it adapt to infected individuals

Plasmodium falciparum is responsible for the most severe forms of human malaria. Invasion of host red blood cells is an essential step of the complex life cycle of this parasite. During the process of invasion, P. falciparum, which appears in the stage of a merozoite, is exposed to antibodies from the immune system. Consequently, the proteins of the merozoite that interact with red blood cells are a possible weak point, and thus a very clear target to develop vaccines. Alfred Corts, an ICREA researcher working at IRB Barcelona and an expert in molecular parasitology, together with researchers from the National Institute for Medical Research (NIMR) in London, have discovered that the parasite has the ability to switch on and off the expression of some of the proteins it uses to enter its victims red blood cells. The researchers believe that this ability makes the parasite more adaptable when attempting to invade the cells. The study is published in Fridays issue of Plos Pathogens, the scientific journal with the greatest impact on the field of Parasitology.

30 genes are know to be involved in the process of invasion. Now, the scientists have found that P. falciparum can activate and deactivate the expression of 7 of these genes (and their corresponding proteins) without compromising the parasites ability to enter normal or modified red blood cells. According to Corts, this suggests that the varied expression of these genes may help the parasite to escape the host organisms immune responses, although the researcher points out that this is yet to be confirmed.

The researchers discovered that the silencing mechanism happens at the epigenetic level, meaning that the parasite stops expressing a certain gene without changing the underlying genetic information, and that the mechanism is flexible, adaptable and easily reversible. This means that the parasite can re-express the proteins relatively easily when infecting another individual or silence th
'"/>

Contact: Sonia Armengou
armengou@irbbarcelona.org
34-934-037-255
Institute for Research in Biomedicine (IRB)
2-Aug-2007


Page: 1 2

Related biology news :

1. Identified main genetic variants involved in response to HIV
2. Weizmann Institute scientists discover a control mechanism for metastasis
3. New mechanism links smoking to lung damage
4. Identifying the mechanism behind a genetic susceptibility to type 2 diabetes
5. A new plant-bacterial symbiotic mechanism promising
6. MIT IDs mechanism behind fear
7. Tracing Parkinsons lethal mechanism
8. Researchers shed light on mechanism of action used by anti-cancer drug
9. A new plant-bacterial symbiotic mechanism promising for crop applications
10. Simulations unravel outer membrane transport mechanism
11. Cytomegalovirus exacerbates atherosclerosis through an autoimmune mechanism

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: